TIAX

TIAX is a technology development company that specializes in transitioning early-stage innovations into functional products and intellectual property. Established in 2002 by Kenan Sahin following the acquisition of Arthur D. Little's Technology & Innovation business, the company maintains extensive laboratory facilities to support R&D across energy, safety, and healthcare sectors. In the life sciences and healthcare domain, TIAX focuses on the development of wearable physiological sensors, chemical and biological hazard detection systems, and advanced materials for medical devices. The company operates as a bridge between basic research and commercialization, often spinning off successful technologies into independent entities. TIAX's business model relies heavily on contract research, government grants, and the licensing of its proprietary technology portfolio.